Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2323
2.750
Why?
Smoking
20
2019
1463
1.280
Why?
Bronchi
13
2018
240
1.230
Why?
Carcinoma in Situ
5
2019
45
1.120
Why?
Carcinoma, Squamous Cell
10
2018
620
0.780
Why?
Carcinogens
4
2012
110
0.770
Why?
Chemoprevention
3
2019
89
0.730
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
81
0.730
Why?
Lung
16
2020
3741
0.630
Why?
Carcinoma, Small Cell
7
2008
168
0.500
Why?
Bronchoscopy
9
2019
208
0.500
Why?
Urethane
3
2012
41
0.490
Why?
Bronchopulmonary Dysplasia
2
2019
375
0.480
Why?
Pulmonary Alveoli
4
2012
366
0.470
Why?
Sputum
8
2019
304
0.470
Why?
Iloprost
2
2012
45
0.460
Why?
Hyperplasia
7
2011
170
0.460
Why?
Precancerous Conditions
7
2020
161
0.450
Why?
Neprilysin
3
1998
47
0.430
Why?
Biomarkers, Tumor
7
2015
1182
0.400
Why?
Quinazolines
2
2012
242
0.400
Why?
Piperidines
2
2012
190
0.390
Why?
Biopsy
11
2019
1085
0.390
Why?
Antineoplastic Agents
4
2013
2058
0.390
Why?
DNA Copy Number Variations
1
2011
169
0.350
Why?
Bombesin
5
1998
12
0.350
Why?
Genetic Markers
1
2011
339
0.350
Why?
Amidohydrolases
3
1998
30
0.340
Why?
Neurosecretory Systems
4
2004
30
0.330
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1044
0.320
Why?
Ki-67 Antigen
3
2015
106
0.320
Why?
Tocopherols
1
2009
22
0.320
Why?
Isotretinoin
1
2009
23
0.320
Why?
Vasodilator Agents
1
2011
321
0.320
Why?
ErbB Receptors
1
2012
601
0.310
Why?
Mass Screening
3
2008
1152
0.300
Why?
Membrane Proteins
2
2008
1108
0.300
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
950
0.290
Why?
Neovascularization, Pathologic
6
2015
291
0.290
Why?
Respiratory Mucosa
2
2008
305
0.260
Why?
Adenocarcinoma
6
2012
888
0.250
Why?
Hypoxia
1
2012
1031
0.240
Why?
Chromosomes, Human, Pair 3
4
2000
48
0.230
Why?
Carcinoma, Bronchogenic
2
2002
19
0.220
Why?
Chromosome Aberrations
4
2013
147
0.210
Why?
Middle Aged
28
2019
30893
0.210
Why?
Aged
25
2019
21971
0.210
Why?
Tomography, Spiral Computed
1
2002
27
0.200
Why?
Humans
53
2020
128524
0.190
Why?
Female
33
2019
68127
0.190
Why?
Sensitivity and Specificity
10
2010
1820
0.190
Why?
Smokers
2
2019
137
0.190
Why?
Placebos
2
2019
201
0.180
Why?
Double-Blind Method
2
2019
1860
0.180
Why?
Lung Diseases
5
2015
722
0.180
Why?
Small Cell Lung Carcinoma
2
2012
88
0.180
Why?
Tomography, X-Ray Computed
2
2020
2521
0.170
Why?
Male
30
2019
62883
0.170
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
91
0.160
Why?
Tumor Cells, Cultured
6
1998
927
0.160
Why?
Neuropeptides
4
1998
72
0.160
Why?
Remission Induction
1
2019
269
0.150
Why?
Peptides
3
1996
909
0.150
Why?
In Situ Hybridization, Fluorescence
6
2010
313
0.150
Why?
Blotting, Western
4
2012
1168
0.150
Why?
Genes, p53
1
1997
70
0.140
Why?
Lung Diseases, Obstructive
1
1997
44
0.140
Why?
Antibodies, Monoclonal
3
2010
1355
0.140
Why?
Immunohistochemistry
8
2015
1669
0.130
Why?
Point Mutation
1
1997
224
0.130
Why?
Proteomics
2
2015
1004
0.130
Why?
Radiation Injuries, Experimental
1
1996
22
0.130
Why?
Bradykinin
1
1996
45
0.130
Why?
Endopeptidases
1
1996
83
0.130
Why?
Chromosomal Instability
2
2013
18
0.130
Why?
Mice
10
2012
16579
0.120
Why?
Animals
13
2013
34501
0.120
Why?
Smoking Cessation
1
2019
408
0.120
Why?
Hyperoxia
1
1996
87
0.120
Why?
Multiple Pulmonary Nodules
1
2015
19
0.120
Why?
Gene Expression
3
1998
1462
0.110
Why?
Methylcholanthrene
2
2012
21
0.110
Why?
Risk Factors
5
2019
9727
0.110
Why?
Mice, Transgenic
5
2009
2069
0.110
Why?
Antigens
1
1996
352
0.110
Why?
Butylated Hydroxytoluene
2
2012
38
0.110
Why?
Aged, 80 and over
8
2015
7040
0.110
Why?
Microarray Analysis
1
2013
121
0.110
Why?
Algorithms
3
2020
1616
0.110
Why?
Stem Cells
1
2018
578
0.110
Why?
Mutation
4
2000
3692
0.110
Why?
Epithelium
4
2018
306
0.110
Why?
Intramolecular Oxidoreductases
2
2004
62
0.100
Why?
Risk
5
2012
852
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
127
0.100
Why?
Biological Products
1
1996
200
0.100
Why?
Epithelial Cells
3
2007
1036
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
626
0.100
Why?
Volatile Organic Compounds
1
2012
54
0.100
Why?
Case-Control Studies
8
2012
3326
0.100
Why?
Immunoenzyme Techniques
1
2012
206
0.100
Why?
Cell Division
4
2000
779
0.100
Why?
Sleep Apnea Syndromes
1
2012
78
0.090
Why?
Dose-Response Relationship, Drug
2
2010
1943
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
129
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
56
0.090
Why?
Veterans
1
2002
1414
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
194
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
231
0.090
Why?
Antioxidants
2
2012
543
0.090
Why?
Proteins
1
1996
936
0.080
Why?
Cell Line
5
2013
2731
0.080
Why?
Plants, Toxic
1
1989
22
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Calcium
1
1996
1178
0.080
Why?
Predictive Value of Tests
4
2009
1936
0.080
Why?
Genome-Wide Association Study
2
2013
1337
0.080
Why?
Disease Progression
5
2018
2603
0.080
Why?
Cell Proliferation
2
2018
2335
0.080
Why?
Adult
16
2018
35315
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
425
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Chromosome Deletion
1
1989
102
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
35
0.080
Why?
Airway Obstruction
3
2009
149
0.080
Why?
GPI-Linked Proteins
1
2008
67
0.070
Why?
Respiratory System
1
1989
153
0.070
Why?
Neoplasm Invasiveness
4
2015
480
0.070
Why?
Fluorescence
3
2009
158
0.070
Why?
Alkaline Phosphatase
1
2008
142
0.070
Why?
Polymorphism, Genetic
1
2011
639
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
304
0.070
Why?
Inflammation
1
2018
2664
0.070
Why?
Molecular Targeted Therapy
1
2010
387
0.070
Why?
Cell Transformation, Neoplastic
1
2009
325
0.070
Why?
Fibroblasts
3
1998
939
0.070
Why?
Molecular Sequence Data
5
1998
2818
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
259
0.070
Why?
Pulmonary Surfactants
2
1999
106
0.070
Why?
Exons
2
1998
337
0.070
Why?
Early Detection of Cancer
1
2010
368
0.070
Why?
Follow-Up Studies
2
2015
4898
0.060
Why?
MicroRNAs
1
2012
671
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2065
0.060
Why?
ROC Curve
3
2015
501
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
814
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
391
0.060
Why?
Recombinant Proteins
3
1998
1284
0.060
Why?
RNA, Messenger
3
1998
2674
0.060
Why?
Biomarkers
3
2010
3881
0.060
Why?
Polymerase Chain Reaction
3
1998
1019
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
24
0.060
Why?
Acromegaly
1
2004
12
0.060
Why?
Protein Kinase Inhibitors
1
2010
872
0.060
Why?
Cytokines
1
2012
1985
0.060
Why?
Rats
4
2004
5168
0.050
Why?
Adrenocorticotropic Hormone
1
2004
132
0.050
Why?
Neoplasm Recurrence, Local
1
2009
957
0.050
Why?
Smoke
1
2004
132
0.050
Why?
Base Sequence
3
1998
2134
0.050
Why?
Solitary Pulmonary Nodule
1
2002
20
0.050
Why?
Cross-Sectional Studies
2
2018
5040
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
501
0.050
Why?
Sex Factors
1
2007
1949
0.050
Why?
Radiation Dosage
1
2002
152
0.050
Why?
Pulmonary Fibrosis
2
1998
374
0.050
Why?
Hospitals, Veterans
1
2002
257
0.050
Why?
Reproducibility of Results
1
2008
3023
0.040
Why?
Gene Expression Regulation
1
1989
2506
0.040
Why?
Cohort Studies
4
2015
5369
0.040
Why?
Amino Acid Sequence
3
1994
2041
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Feasibility Studies
1
2002
860
0.040
Why?
Light
1
2001
355
0.040
Why?
Autocrine Communication
1
1998
43
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Signal Transduction
3
1998
4829
0.040
Why?
Desmoglein 3
1
2018
16
0.040
Why?
Loss of Heterozygosity
2
2013
46
0.040
Why?
DNA Primers
2
1998
510
0.040
Why?
Up-Regulation
2
2005
826
0.040
Why?
Paracrine Communication
1
1998
60
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Neoplasm Transplantation
1
1998
258
0.040
Why?
Time
1
2018
75
0.040
Why?
Gene Expression Profiling
1
2005
1687
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
37
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
12
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
28
0.040
Why?
Cell Cycle Checkpoints
1
2018
95
0.040
Why?
Genes, Tumor Suppressor
1
1998
86
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
92
0.040
Why?
Likelihood Functions
1
1998
136
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
69
0.040
Why?
DNA, Complementary
1
1998
267
0.040
Why?
Neoplasm Staging
2
2012
1288
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
283
0.040
Why?
Codon
1
1997
86
0.040
Why?
United States
2
2011
13876
0.030
Why?
Introns
1
1998
245
0.030
Why?
Mice, Nude
1
1998
682
0.030
Why?
Treatment Outcome
1
2011
10163
0.030
Why?
Membrane Glycoproteins
1
1999
466
0.030
Why?
Immunoassay
2
1998
103
0.030
Why?
Incidence
3
2010
2619
0.030
Why?
Enzyme Activation
1
1998
799
0.030
Why?
RNA, Neoplasm
1
1996
87
0.030
Why?
Glycopeptides
1
1996
44
0.030
Why?
Mesothelioma
1
1996
38
0.030
Why?
Image Processing, Computer-Assisted
1
2020
732
0.030
Why?
Antigens, CD
2
1998
479
0.030
Why?
Machine Learning
1
2020
432
0.030
Why?
Sequence Analysis, DNA
1
1998
773
0.030
Why?
Proto-Oncogene Proteins
1
2018
634
0.030
Why?
Databases, Factual
1
2020
1268
0.030
Why?
Cell Cycle Proteins
1
2018
580
0.030
Why?
Receptors, Peptide
1
1994
17
0.030
Why?
Myelin Sheath
1
1996
159
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Erythrocyte Membrane
1
1994
49
0.030
Why?
Blotting, Southern
1
1993
68
0.030
Why?
Prospective Studies
3
2012
7043
0.030
Why?
Blotting, Northern
1
1993
199
0.030
Why?
Neoplasm Metastasis
1
1996
608
0.030
Why?
Endoscopy
1
2015
267
0.030
Why?
Cells, Cultured
2
2007
4008
0.030
Why?
DNA, Neoplasm
1
1993
159
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Liver Neoplasms
1
1998
640
0.030
Why?
Fluorescent Antibody Technique
1
1993
374
0.030
Why?
Dinoprostone
2
2004
187
0.030
Why?
Colorado
1
2002
4392
0.020
Why?
Enzyme Inhibitors
1
1996
811
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
126
0.020
Why?
Cloning, Molecular
1
1993
522
0.020
Why?
Breath Tests
1
2012
89
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1333
0.020
Why?
Iceland
1
2011
10
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Spain
1
2011
36
0.020
Why?
Respiratory Tract Diseases
1
1992
150
0.020
Why?
Netherlands
1
2011
77
0.020
Why?
Cattle
1
1993
962
0.020
Why?
Rats, Sprague-Dawley
1
1996
2245
0.020
Why?
Administration, Oral
1
2012
757
0.020
Why?
Meta-Analysis as Topic
1
2011
167
0.020
Why?
Severity of Illness Index
1
2018
2736
0.020
Why?
Carrier Proteins
1
1994
731
0.020
Why?
Prognosis
2
2012
3780
0.020
Why?
Flow Cytometry
1
1993
1141
0.020
Why?
Receptor, IGF Type 1
1
2009
65
0.020
Why?
Area Under Curve
1
2010
281
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Cystic Fibrosis
1
1998
1057
0.020
Why?
Erythrocytes
1
1994
670
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
475
0.020
Why?
Mass Spectrometry
1
2010
660
0.020
Why?
Pilot Projects
1
2012
1558
0.020
Why?
Genome, Human
1
2009
392
0.020
Why?
Models, Statistical
1
2010
625
0.020
Why?
Amino Acids
1
1989
474
0.020
Why?
Disease Models, Animal
1
1996
3943
0.020
Why?
Genotype
1
2011
1831
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
89
0.010
Why?
Genomics
1
2009
716
0.010
Why?
Epoprostenol
1
2004
134
0.010
Why?
Bronchiolitis
1
2004
89
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
937
0.010
Why?
Autoantibodies
1
2010
1463
0.010
Why?
Fruit
1
2003
131
0.010
Why?
Vegetables
1
2003
147
0.010
Why?
Pituitary Neoplasms
1
2004
184
0.010
Why?
Genetic Predisposition to Disease
1
2011
2266
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
756
0.010
Why?
Respiratory Function Tests
1
2004
582
0.010
Why?
Adenoma
1
2004
214
0.010
Why?
Regression Analysis
1
2003
983
0.010
Why?
Single-Blind Method
1
2001
269
0.010
Why?
Weight Gain
1
2004
505
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
56
0.010
Why?
Carcinoma
1
2001
214
0.010
Why?
RNA
1
2005
881
0.010
Why?
Bronchoscopes
1
1998
2
0.010
Why?
Endoglin
1
1998
19
0.010
Why?
Random Allocation
1
1998
346
0.010
Why?
Retrospective Studies
1
2015
14460
0.010
Why?
Genetic Linkage
1
1998
299
0.010
Why?
Reference Values
1
1998
780
0.010
Why?
Comorbidity
1
2001
1540
0.010
Why?
Longitudinal Studies
1
2003
2697
0.010
Why?
Linear Models
1
1998
816
0.010
Why?
Tumor Suppressor Protein p53
1
2000
507
0.010
Why?
Diet
1
2003
1200
0.010
Why?
Receptors, Cell Surface
1
1998
371
0.010
Why?
Analysis of Variance
1
1998
1271
0.010
Why?
Alleles
1
1998
845
0.010
Why?
Young Adult
1
2011
12320
0.010
Why?
Infant, Premature
1
1998
536
0.010
Why?
Risk Assessment
1
2004
3256
0.010
Why?
Chromatography, Affinity
1
1994
83
0.010
Why?
CD47 Antigen
1
1994
27
0.010
Why?
Genes
1
1994
226
0.010
Why?
Moths
1
1994
38
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
323
0.010
Why?
Endothelium, Vascular
1
2000
871
0.010
Why?
Cytoplasm
1
1994
258
0.010
Why?
Carcinoid Tumor
1
1992
24
0.010
Why?
Chromosome Mapping
1
1994
505
0.010
Why?
Lymphocytes
1
1994
366
0.010
Why?
Adolescent
1
2011
20213
0.010
Why?
Transfection
1
1994
895
0.010
Why?
Mice, Inbred BALB C
1
1994
1229
0.010
Why?
Dyspnea
1
1992
234
0.010
Why?
Binding Sites
1
1994
1239
0.010
Why?
Fibrosis
1
1992
522
0.010
Why?
Phenotype
1
1998
3050
0.000
Why?
Aging
1
1998
1770
0.000
Why?
Infant, Newborn
1
1998
5687
0.000
Why?
Infant
1
1998
8913
0.000
Why?
Child, Preschool
1
1998
10373
0.000
Why?
Child
1
1998
20721
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)